Tickerplace logo

Tickerplace

NeoGenomics, Inc. logo

NEONeoGenomics, Inc.

NEO Stock Price, Valuation & Chart | NeoGenomics, Inc.

Compare
$16.650-0.60 (-3.48%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Medical - Diagnostics & Research
OverviewFinancialsDividendsRatios

NEO Historical price chart

NEO Key Stats

Market Capitalization2.17B
PE Ratio128.08
EPS0.13
Trading Volume2.31M
Today's High/Low17.47/16.45
Dividend Yield0.00
52 Week High/Low20.15/7.07
Shares Outstanding130.21M
NEO Financial Statement
NEO Analyst ratings
NEO Analysis & performance metrics

NEO Company profile

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services…

NEO Management team

Management
Andrew A. Lukowiak Ph.D.
Chief Innovation Officer
Alicia C. Olivo
Executive Vice President of Business Development, General Counsel & Corporate Secretary
Gregory D. Aunan
Senior Vice President & Chief Accounting Officer
Hutan Hashemi J.D.
Chief Compliance Officer
Warren StoneCOO
President & Chief Operating Officer
Gary Passman
Chief People & Culture Officer
Anthony P. ZookCEO
Chief Executive Officer & Director
Kareem M. Saad
Head of Strategy, Business Development & Transformation
Total 8 executives

NEO Frequently asked questions

What is NeoGenomics, Inc. (NEO) Stock Price?

Current stock price of NeoGenomics, Inc. (NEO) stock is $16.650. The stock price is -3.48% lower in the session. The intraday range can be seen from this page. Volume of NeoGenomics, Inc. (NEO) stock is 2.31M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the NeoGenomics, Inc. (NEO) stock price going up or down today?

The stock price of NeoGenomics, Inc. (NEO) can change with earnings, company news, and overall market sentiment. NeoGenomics, Inc. operates in the Healthcare / Medical - Diagnostics & Research market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the NeoGenomics, Inc. stock expensive at its current price?

Whether NeoGenomics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NEO on this page is 128.08. EPS on this page is 0.13. Compare those figures with peers and growth expectations before deciding if the current NeoGenomics, Inc. price is justified.

How has the stock price of NeoGenomics, Inc. (NEO) performed historically?

Historical performance for NeoGenomics, Inc. (NEO) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NEO reacted to past earnings and market events.

Should I buy NeoGenomics, Inc. (NEO) stock, at this price?

Buying NeoGenomics, Inc. (NEO) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.